164 related articles for article (PubMed ID: 23273834)
1. Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain.
Ragavendran JV; Laferrière A; Xiao WH; Bennett GJ; Padi SS; Zhang J; Coderre TJ
J Pain; 2013 Jan; 14(1):66-78. PubMed ID: 23273834
[TBL] [Abstract][Full Text] [Related]
2. A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin.
Ali G; Subhan F; Abbas M; Zeb J; Shahid M; Sewell RD
Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1129-40. PubMed ID: 26134846
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive effects of sinomenine in a rat model of neuropathic pain.
Zhu Q; Sun Y; Zhu J; Fang T; Zhang W; Li JX
Sci Rep; 2014 Dec; 4():7270. PubMed ID: 25434829
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive effect of LMH-2, a new sigma-1 receptor antagonist analog of haloperidol, on the neuropathic pain of diabetic mice.
Ventura-Martínez R; Ángeles-López GE; González-Ugalde D; Domínguez-Páez T; Navarrete-Vázquez G; Jaimez R; Déciga-Campos M
Biomed Pharmacother; 2024 May; 174():116524. PubMed ID: 38574622
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis.
Evans AA; Jesus CHA; Martins LL; Fukuyama AH; Gasparin AT; Crippa JA; Zuardi AW; Hallak JEC; Genaro K; de Castro Junior CJ; Zanoveli JM; Cunha JMD
Cannabis Cannabinoid Res; 2024 Jun; 9(3):728-739. PubMed ID: 37205869
[No Abstract] [Full Text] [Related]
6. Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome.
Adami G; Fassio A; Rossini M; Montanari F; Manfrè S; Bonasera G; Bertelle D; Benini C; Viapiana O; Braga V; Gatti D
Clin Exp Rheumatol; 2024 May; 42(5):961-966. PubMed ID: 38079346
[TBL] [Abstract][Full Text] [Related]
7. Topical coapplication of hyaluronan with transdermal drug delivery enhancers attenuates inflammatory and neuropathic pain.
Bonet IJM; Araldi D; Green PG; Levine JD
Pain; 2023 Dec; 164(12):2653-2664. PubMed ID: 37467181
[TBL] [Abstract][Full Text] [Related]
8. Analgesic Microneedle Patch for Neuropathic Pain Therapy.
Xie X; Pascual C; Lieu C; Oh S; Wang J; Zou B; Xie J; Li Z; Xie J; Yeomans DC; Wu MX; Xie XS
ACS Nano; 2017 Jan; 11(1):395-406. PubMed ID: 28001346
[TBL] [Abstract][Full Text] [Related]
9. Basolateral amygdala lesion inhibits the development of pain chronicity in neuropathic pain rats.
Li Z; Wang J; Chen L; Zhang M; Wan Y
PLoS One; 2013; 8(8):e70921. PubMed ID: 23940666
[TBL] [Abstract][Full Text] [Related]
10. Transient immune activation without loss of intraepidermal innervation and associated Schwann cells in patients with complex regional pain syndrome.
Hartmannsberger B; Scriba S; Guidolin C; Becker J; Mehling K; Doppler K; Sommer C; Rittner HL
J Neuroinflammation; 2024 Jan; 21(1):23. PubMed ID: 38233858
[TBL] [Abstract][Full Text] [Related]
11. Alpha-lipoic acid reduces nociception by reducing oxidative stress and neuroinflammation in a model of complex regional pain syndrome type I in mice.
Rodrigues P; Cassanego GB; Peres DS; Viero FT; Kudsi SQ; Ruviaro NA; Aires KV; Portela VM; Bauermann LF; Trevisan G
Behav Brain Res; 2024 Feb; 459():114790. PubMed ID: 38040057
[TBL] [Abstract][Full Text] [Related]
12. Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies?
Bennett GJ
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7737-8. PubMed ID: 10393890
[TBL] [Abstract][Full Text] [Related]
13. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.
Obrosova IG
Neurotherapeutics; 2009 Oct; 6(4):638-47. PubMed ID: 19789069
[TBL] [Abstract][Full Text] [Related]
14. Examination of the effects of vitexin and vitexin-loaded solid lipid nanoparticles on neuropathic pain and possible mechanisms of action.
Eken H; Bektas Turkmen N; Senel B; Arslan R
Neuropharmacology; 2024 Aug; 253():109961. PubMed ID: 38657947
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of antinociceptive gene therapies in animal models of diabetic neuropathic pain.
Wang Y; Nowicki MO; Wang X; Arnold WD; Fernandez SA; Mo X; Wechuk J; Krisky D; Goss J; Wolfe D; Popovich PG; Lawler S; Chiocca EA
Gene Ther; 2013 Jul; 20(7):742-50. PubMed ID: 23235561
[TBL] [Abstract][Full Text] [Related]
16. The effect of protocatechuic acid on neuropathic pain and possible mechanism.
Cici MO; Bektas N
Indian J Pharmacol; 2023; 55(5):315-321. PubMed ID: 37929410
[TBL] [Abstract][Full Text] [Related]
17. Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain.
Serafini RA; Estill M; Pekarskaya EA; Sakloth F; Shen L; Javitch JA; Zachariou V
Neuropsychopharmacology; 2023 Oct; 48(11):1680-1689. PubMed ID: 37474762
[TBL] [Abstract][Full Text] [Related]
18. The association of self-reported symptoms of central sensitization and sleep disturbances in neuropathic pain.
Sachau J; Kersebaum D; Hüllemann P; Adolf D; Kabelitz M; Keller T; Freynhagen R; Tölle TR; Binder A; Baron R
Pain Rep; 2023 Sep; 8(5):e1098. PubMed ID: 37772033
[TBL] [Abstract][Full Text] [Related]
19. Sustained Relief of Complex Regional Pain Syndrome (CRPS) Pain Following a 60-Day Peripheral Nerve Stimulation: A Report of Three Cases.
Gutierrez GJ; Zurn CA; Crosby ND
Cureus; 2024 Feb; 16(2):e54458. PubMed ID: 38510888
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
